- Home
- IRM vs BNTX Comparison
IRM vs BNTX Comparison
Compare IRM & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRM
- BNTX
- Stock Information
- Founded
- IRM 1951
- BNTX 2008
- Country
- IRM United States
- BNTX Germany
- Employees
- IRM N/A
- BNTX N/A
- Industry
- IRM Real Estate Investment Trusts
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IRM Real Estate
- BNTX Health Care
- Exchange
- IRM Nasdaq
- BNTX Nasdaq
- Market Cap
- IRM 30.3B
- BNTX 26.4B
- IPO Year
- IRM 1996
- BNTX 2019
- Fundamental
- Price
- IRM $100.40
- BNTX $99.26
- Analyst Decision
- IRM Strong Buy
- BNTX Strong Buy
- Analyst Count
- IRM 6
- BNTX 18
- Target Price
- IRM $120.17
- BNTX $139.49
- AVG Volume (30 Days)
- IRM 1.3M
- BNTX 1.2M
- Earning Date
- IRM 11-05-2025
- BNTX 11-03-2025
- Dividend Yield
- IRM 3.13%
- BNTX N/A
- EPS Growth
- IRM N/A
- BNTX N/A
- EPS
- IRM 0.14
- BNTX N/A
- Revenue
- IRM $6,443,114,000.00
- BNTX $3,380,387,551.00
- Revenue This Year
- IRM $12.91
- BNTX N/A
- Revenue Next Year
- IRM $9.03
- BNTX $13.50
- P/E Ratio
- IRM $713.95
- BNTX N/A
- Revenue Growth
- IRM 10.72
- BNTX 6.98
- 52 Week Low
- IRM $72.33
- BNTX $81.20
- 52 Week High
- IRM $130.24
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- IRM 65.12
- BNTX 50.29
- Support Level
- IRM $96.07
- BNTX N/A
- Resistance Level
- IRM $99.16
- BNTX $104.48
- Average True Range (ATR)
- IRM 2.32
- BNTX 3.81
- MACD
- IRM 1.15
- BNTX -4.06
- Stochastic Oscillator
- IRM 95.38
- BNTX 86.40
About IRM Iron Mountain Incorporated (Delaware)Common Stock REIT
Iron Mountain Inc is a record management services provider. It is organized as a REIT. Majority of its revenue comes from its storage business, with the rest coming from value-added services. The firm primarily caters to enterprise clients in developed markets. Its business segments include Global RIM Business; Global Data Center Business; and Corporate and Other Business. It generates maximum revenue from Global RIM Business segment.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.